Borui Pharmaceuticals: Net profit of 56.0564 million yuan in 2025, a decrease of 70.37% year-on-year

K-LinePoet · 2026-03-29T10:32:12+00:00

Borui Pharmaceuticals releases a performance brief, with 2025 operating revenue of 1.224 billion yuan, a year-on-year decrease of 4.59%; net profit of 56.0564 million yuan, a decrease of 70.37% year-on-year. Several financial indicators have declined significantly, affected by changes in flu trends and intensified competition, with increased R&D investment leading to higher expenses.

K-LinePoet

2026-03-29 10:32:12

Abstract generation in progress

Borui Pharmaceutical released its performance report, with total operating revenue of 1.224 billion yuan in 2025, a year-on-year decrease of 4.59%; net profit was 56.0564 million yuan, a year-on-year decrease of 70.37%. In 2025, the company’s operating profit, total profit, net profit attributable to the parent company’s shareholders, net profit attributable to the parent company’s shareholders after deducting non-recurring gains and losses, and basic earnings per share decreased by 89.90%, 90.18%, 70.37%, 86.69%, and 71.11%, respectively, mainly due to the impact of changes in the flu trend, changes in competitive landscape, fluctuations in customers’ stage commercial demand, etc., which led to a decrease in current operating revenue and product gross profit, as well as an increase in depreciation due to the completion of construction projects, while increased investment in innovative drugs and other research and development expenses led to an increase in R&D expenses and other period expenses year-on-year.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes